FORUM · Institut für Management GmbH
Vangerowstraße 18
69115 Heidelberg
Phone: +49 6221 500-500
Fax: +49 6221 500-505
Course Biosimilars Market Access - EU & USA
Biosimilars Market Access
- EU & USA
2020-05-19 2020-05-19 Mercure Hotel MOA Berlin Stephanstr. 41 10559 Berlin +49 30 394043-0 +49 30 394043-999

Biosimilars Market Access in the EU and USA

Settlement agreements in the USA and rights to get to market in the EU

This biosimilars course addresses the available options for market access in the US and EU, including negotiating with the originator.
  • Licencing or challenging patents in the USA
  • Negotiating settlement agreements
  • First to market requirements for the main EU markets
  • Negotiating exclusivity rights for the EU markets

Aims and objectives

This course will prepare you for a biosimilar market entry in the EU or USA. It will give you a deeper understanding of the available options for negotiating, licencing and challenging patents, and how to promote your market entry with a distinctive pre-launch communication and appropriate tenders.
Who should attend
This course is intended for managing directors, market access managers, legal and IP departments involved in placing a biosimilar product on EU or US markets.
Ihre Referenten
Jill M. Browning

Adam Levysohn
Biogen International GmbH, Zug, SWITZERLAND

Dr. Gareth Morgan
CMS Cameron McKenna Nabarro Olswang LLP, London, UNITED KINGDOM

Go forward

Pharma Webcast Global RA & PV

Pharma FORUM Webcast International

We would like to invite you to join our live webcasts, where local regulatory affairs and vigilance experts will inform you every two months of the latest news and trends in global marketing authorisation and drug safety.



e-Learning - Click and learn

The FORUM · Institut für Management GmbH provides flexible education and training with high-quality e-Learning programmes for several topics.

You can access top expertise from anywhere.


More on our quality criteria

Quality guaranteed!

IMI (Innovative Medicines Initiative) defined quality criteria for professional training and education. We follow these criteria and, as a signatory, we are an active partner in further developing and optimising the quality standards.

An aggregate evaluation of participants' feedback on all FORUM's healthcare training courses (evaluation period from 10.2017 - 09.2018 produced a result of 1.6 (based on a school grading system of 1-6).